Auth bypass in Baxter Welch Allyn Connex Cardio
CVE-2021-43935
The impacted products, when configured to use SSO, are affected by an improper authentication vulnerability. This vulnerability allows the application to accept manual entry of any active directory (AD) account provisioned in the application without supplying a password, resulting in access to the application as the supplied AD account, with all associated privileges.
Published · last modified .
CVSS v3 metric
CVSS v3 base score 8.1 (High). Vector: CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:H.
EPSS exploit prediction
EPSS 0.011, 67.3th percentile (scored ); unchanged over 30 days. About EPSS.
Affected products
- Baxter Welch Allyn Connex Cardio
- Baxter Welch Allyn Diagnostic Cardiology Suite — versions 2.1.0
- Baxter Welch Allyn Hscribe Holter Analysis System Firmware
- Baxter Welch Allyn Q-Stress Cardiac Stress Testing System Firmware
- Baxter Welch Allyn Rscribe Resting Ecg System
- Baxter Welch Allyn Vision Express Holter Analysis System
- Baxter Welch Allyn Xscribe Cardiac Stress Testing System Firmware
- Hillrom Welch Allyn Connex Cardio — versions 1.0.0
- Hillrom Welch Allyn Diagnostic Cardiology Suite — versions 2.1.0
- Hillrom Welch Allyn H-Scribe Holter Analysis System — versions 5.01
Weakness classification (CWE)
References
- www.cisa.gov/uscert/ics/advisories/icsma-21-343-01 (US Government Resource, Third Party Advisory, Mitigation)